219 related articles for article (PubMed ID: 22037318)
21. Correlation of preoperative ROMA scores with clinical stage in epithelial ovarian cancer patients.
Li QL; Wang CJ; Qi P; Zhang YX
Clin Transl Oncol; 2017 Oct; 19(10):1260-1267. PubMed ID: 28444641
[TBL] [Abstract][Full Text] [Related]
22. Importance of Preoperative Knowledge of the Biomarker HE4 in Early-stage Endometrial Cancer Regarding Surgical Management.
Presl J; Ovesna P; Novotny Z; Vlasak P; Bouda J; Kostun J; Topolcan O; Kucera R; Bednarikova M; Weinberger V
Anticancer Res; 2017 May; 37(5):2697-2702. PubMed ID: 28476847
[TBL] [Abstract][Full Text] [Related]
23. Predictive value of serum HE4 and CA125 concentrations for lymphatic metastasis of endometrial cancer.
Wang Y; Han C; Teng F; Bai Z; Tian W; Xue F
Int J Gynaecol Obstet; 2017 Jan; 136(1):58-63. PubMed ID: 28099710
[TBL] [Abstract][Full Text] [Related]
24. Serum HE4 superior to CA125 in predicting poorer surgical outcome of epithelial ovarian cancer.
Shen Y; Li L
Tumour Biol; 2016 Nov; 37(11):14765-14772. PubMed ID: 27629144
[TBL] [Abstract][Full Text] [Related]
25. Risk factors for pelvic lymph node metastasis in endometrial cancer.
Li Y; Cong P; Wang P; Peng C; Liu M; Sun G
Arch Gynecol Obstet; 2019 Oct; 300(4):1007-1013. PubMed ID: 31435773
[TBL] [Abstract][Full Text] [Related]
26. [The importance of HE4 in differential diagnosis of endometrial cancer].
Minář L; Klabenešová I; Jandáková E
Ceska Gynekol; 2015 Aug; 80(4):256-63. PubMed ID: 26265413
[TBL] [Abstract][Full Text] [Related]
27. Relations of Serum Visfatin and Resistin Levels with Endometrial Cancer and Factors Associated with its Prognosis.
Ilhan TT; Kebapcilar A; Yilmaz SA; Ilhan T; Kerimoglu OS; Pekin AT; Akyurek F; Unlu A; Celik C
Asian Pac J Cancer Prev; 2015; 16(11):4503-8. PubMed ID: 26107194
[TBL] [Abstract][Full Text] [Related]
28. The clinical significance of DJ-1 and HE4 in patients with endometrial cancer.
Benati M; Montagnana M; Danese E; Paviati E; Giudici S; Ruzzenente O; Franchi M; Lippi G
J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28374920
[TBL] [Abstract][Full Text] [Related]
29. The diagnostic role of human epididymis protein 4 and serum amyloid-A in early-stage endometrial cancer patients.
Omer B; Genc S; Takmaz O; Dirican A; Kusku-Kiraz Z; Berkman S; Gurdol F
Tumour Biol; 2013 Oct; 34(5):2645-50. PubMed ID: 23640061
[TBL] [Abstract][Full Text] [Related]
30. HE4 tumor marker as a predictive factor for lymphatic metastasis in endometrial cancer.
Espiau Romera A; Cuesta Guardiola T; Benito Vielba M; De Bonrostro Torralba C; Coronado Martín PJ; Baquedano Mainar L
Int J Gynaecol Obstet; 2020 Jun; 149(3):265-268. PubMed ID: 32147821
[TBL] [Abstract][Full Text] [Related]
31. Association of preoperative serum HE4 levels on the survival of patients with endometrial cancer.
Insin P; Yimyam Y; Prueksaritanond N
Arch Gynecol Obstet; 2021 Nov; 304(5):1335-1343. PubMed ID: 34109467
[TBL] [Abstract][Full Text] [Related]
32. The role of novel biomarker HE4 in endometrial cancer: a case control prospective study.
Angioli R; Plotti F; Capriglione S; Montera R; Damiani P; Ricciardi R; Aloisi A; Luvero D; Cafà EV; Dugo N; Angelucci M; Benedetti-Panici P
Tumour Biol; 2013 Feb; 34(1):571-6. PubMed ID: 23179397
[TBL] [Abstract][Full Text] [Related]
33. The diagnostic value of human epididymis protein 4 for endometrial cancer is moderate.
Liu J; Han L; Jiao Z
Sci Rep; 2021 Jan; 11(1):575. PubMed ID: 33436780
[TBL] [Abstract][Full Text] [Related]
34. Further insight into prognostic factors in endometrial cancer: the new serum biomarker HE4.
Capriglione S; Plotti F; Miranda A; Lopez S; Scaletta G; Moncelli M; Luvero D; De Cicco Nardone C; Terranova C; Montera R; Angioli R
Expert Rev Anticancer Ther; 2017 Jan; 17(1):9-18. PubMed ID: 27892774
[TBL] [Abstract][Full Text] [Related]
35. A New Risk Index Combining d-Dimer, Fibrinogen, HE4, and CA199 Differentiates Suspecting Endometrial Cancer From Patients With Abnormal Vaginal Bleeding or Discharge.
Ge L; Liu G; Hu K; Huang K; Zhang M; Zhou J; Teng F; Cao J; Dai C; Jia X
Technol Cancer Res Treat; 2020; 19():1533033819901117. PubMed ID: 32167027
[TBL] [Abstract][Full Text] [Related]
36. Preoperative markers for the prediction of high-risk features in endometrial cancer.
Panyavaranant P; Manchana T
World J Clin Oncol; 2020 Jun; 11(6):378-388. PubMed ID: 32874951
[TBL] [Abstract][Full Text] [Related]
37. Novel algorithm including CA-125, HE4 and body mass index in the diagnosis of endometrial cancer.
Knific T; Osredkar J; Smrkolj Š; Tonin I; Vouk K; Blejec A; Frković Grazio S; Rižner TL
Gynecol Oncol; 2017 Oct; 147(1):126-132. PubMed ID: 28735628
[TBL] [Abstract][Full Text] [Related]
38. Clinical Significance of Serum HE4, CA125, CA724, and CA19-9 in Patients With Endometrial Cancer.
Bian J; Sun X; Li B; Ming L
Technol Cancer Res Treat; 2017 Aug; 16(4):435-439. PubMed ID: 27562869
[TBL] [Abstract][Full Text] [Related]
39. Role of serum HE4 as a prognostic marker in carcinoma of the ovary.
Lakshmanan M; Kumar V; Chaturvedi A; Misra S; Gupta S; Akhtar N; Rajan S; Jain K; Garg S
Indian J Cancer; 2019; 56(3):216-221. PubMed ID: 31389384
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic value of serum HE4 in endometrial cancer: a meta-analysis.
Bie Y; Zhang Z
World J Surg Oncol; 2014 May; 12():169. PubMed ID: 24885319
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
